Almanack Investment Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-8,029
| Closed | -$266K | – | 178 |
|
|
2023
Q3 | $266K | Sell |
8,029
-7,568
| -49% | -$251K | 0.05% | 127 |
|
|
2023
Q2 | $572K | Sell |
15,597
-2,129
| -12% | -$78.1K | 0.1% | 84 |
|
|
2023
Q1 | $723K | Sell |
17,726
-633
| -3% | -$25.8K | 0.14% | 72 |
|
|
2022
Q4 | $941K | Buy |
+18,359
| New | +$941K | 0.2% | 55 |
|
|
2022
Q3 | – | Sell |
-30,806
| Closed | -$1.62M | – | 871 |
|
|
2022
Q2 | $1.62M | Buy |
30,806
+5,588
| +22% | +$293K | 0.16% | 94 |
|
|
2022
Q1 | $1.31M | Buy |
25,218
+282
| +1% | +$14.6K | 0.11% | 121 |
|
|
2021
Q4 | $1.47M | Buy |
24,936
+1,885
| +8% | +$111K | 0.12% | 116 |
|
|
2021
Q3 | $991K | Buy |
23,051
+1,896
| +9% | +$81.5K | 0.09% | 162 |
|
|
2021
Q2 | $828K | Sell |
21,155
-1,846
| -8% | -$72.3K | 0.08% | 159 |
|
|
2021
Q1 | $833K | Sell |
23,001
-528
| -2% | -$19.1K | 0.08% | 156 |
|
|
2020
Q4 | $866K | Buy |
23,529
+7,212
| +44% | +$265K | 0.1% | 130 |
|
|
2020
Q3 | $605K | Buy |
16,317
+3,754
| +30% | +$139K | 0.07% | 173 |
|
|
2020
Q2 | $390K | Sell |
12,563
-1,811
| -13% | -$56.2K | 0.07% | 150 |
|
|
2020
Q1 | $445K | Buy |
14,374
+6,442
| +81% | +$199K | 0.1% | 134 |
|
|
2019
Q4 | $295K | Sell |
7,932
-70
| -0.9% | -$2.6K | 0.06% | 146 |
|
|
2019
Q3 | $273K | Sell |
8,002
-89
| -1% | -$3.04K | 0.05% | 171 |
|
|
2019
Q2 | $333K | Buy |
+8,091
| New | +$333K | 0.08% | 129 |
|
|
2019
Q1 | – | Sell |
-4,768
| Closed | -$197K | – | 186 |
|
|
2018
Q4 | $197K | Buy |
4,768
+63
| +1% | +$2.6K | 0.06% | 153 |
|
|
2018
Q3 | $198K | Buy |
+4,705
| New | +$198K | 0.05% | 178 |
|
|
2017
Q2 | – | Sell |
-7,693
| Closed | -$250K | – | 197 |
|
|
2017
Q1 | $250K | Buy |
+7,693
| New | +$250K | 0.19% | 84 |
|